全球圆锥角膜治疗市场 – 行业趋势和 2030 年预测

圆锥角膜治疗市场分析和规模

眼部疾病病例的增加推动了圆锥角膜治疗市场的发展。过度暴露于太阳的紫外线以及角膜酶失衡会增加出现眼部疾病的风险，从而促进了圆锥角膜治疗市场的增长。根据《美国眼科学杂志》的报道，每 100,000 人中约有 50-200 人患有圆锥角膜。在圆锥角膜治疗市场运营的主要市场参与者正在大力投资研发，以开发有效的圆锥角膜解决方案。

 Data Bridge Market Research 分析了 2023-2030 年预测期内圆锥角膜治疗市场的增长率。在上述预测期内，圆锥角膜治疗市场的预期复合年增长率约为 4.2%。2022 年市场价值为 2.8036 亿美元，到 2030 年将增长至 3.8964 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

圆锥角膜治疗市场范围和细分

Market Definition

Keratoconus is a progressive type of eye disease that causes thinning of cornea and alters the cornea into dome or cone like shape. Keratoconus also changes the vision that cannot be corrected with the eye-glasses. The symptoms of keratoconus include nearsightedness, light sensitivity, blurred vision, and irregular astigmatism. Treatment for keratoconus disorder highly depends on the severity of condition and how rapidly the progression of the condition takes place. Mild to moderate keratoconus can be widely treated with contact lenses or eyeglasses.

Global Keratoconus Treatment Market Dynamics

Drivers

• Increasing Incidence of Keratoconus Disorder

There has been a rise in cases with keratoconus disorder worldwide. The increasing occurrence and incidence of keratoconus disorders also surge the demand for various treatment options such as lenses, surgeries, and corneal cross-linking. According to the American Journal of Ophthalmology records, about 50-200 of every 100,000 people are suffering from keratoconus. In the U.S., around 54.5 per 100,000 people were affected with this disease. In addition to this, around 3 million people are affected by this disease globally. Therefore, rising keratoconus cases boost the use of different treatment methods such as intacs and corneal transplants, boosting market growth.

• Rising Ultraviolet Radiations and Sun Exposure

As per the study titled “Epidemiology of Keratoconus Worldwide” by the Open Opthalmology Journal, ultraviolet radiation is considered as one of the primary causes for the development of keratoconus due to its oxidative damage. This can be demonstrated by its high occurrence of keratoconus in hot and sunny areas. Higher incidence of keratoconus has been witnessed in Saudi Arabia, Iran, New Zealand, Israel, and some Pacific Islands. This is due to the high exposure to the sun and UV rays. Therefore, ultraviolet radiations and sun exposure are most likely to cause keratoconus disorder, thus boosting the keratoconus treatment market.

Opportunities

• Increasing Product Launches and Developments

Increasing number of approvals by the FDA for numerous new drugs and treatments for keratoconus boosts the growth of the keratoconus treatment market. For instance, Bausch + Lomb received 510(k) clearance for the Tangible Hydra-PEG Custom Contact Lens Coating Technology on Boston Gas Permeable Lens Materials and Zenlens Family of Scleral Lenses in February 2019. With this coating technology, several eye care practitioners have the opportunity to improve contact lens customization for their patients using these Bausch + Lomb lens offerings. Furthermore, Bausch + Lomb announced that its Specialty Vision Products business launched the Zenlens diagnostic lenses in a new 28 lens set format in December 2016. Adding to it, the new 28 lens set adds four diagnostic lenses with toric peripheral curves. Therefore, all these advancements provide lucrative growth opportunities to the market players.

• Growing Treatment Options for Keratoconus Patients

The current treatment option, which includes cornea cross-linking, intrastromal corneal ring segments, and other combined treatments, provides the corneal clinicians a variety of treatment options for the visual rehabilitation of keratoconus patients. In patients with mild issue, eyeglasses or soft contact lenses are preferred. But as the disease evolves and the cornea thins and becomes irregular in shape, and in that case, glasses and regular soft contact lens no longer offers accurate vision correction. Some other treatment options include corneal collagen custom soft contact lenses, cross-linking or CXL, gas permeable contact lenses. Thus, this factor boosts the market growth.

Restraints/Challenges

• Lack of Awareness

Numerous eye-related problems develop very slowly and are caused because of carelessness. Some of these problems are minimal, while some need special treatments that are expensive. In highly developing regions, a large number of people do not have enough expenditure to avail treatment for these diseases. Furthermore, many of them have inadequate knowledge about such diseases that, further increases the severity. According to the National Keratoconus Foundation, keratoconus occurs in around 1 out of every 2,000 people among the general population. Keratoconus is not very common and thus there is less awareness among the public in spite of their noisome symptoms and complications. The lack of knowledge which leads to the loss in timely management of keratoconus treatments hamper the market growth.  

本圆锥角膜治疗市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关圆锥角膜治疗市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。

COVID-19 对全球圆锥角膜治疗市场的影响

COVID-19 对市场增长产生了重大影响。制造业、本地企业和投资受到社会和经济因素的严重影响。COVID-19 大流行影响了圆锥角膜治疗市场及其财务能力。它还影响了几家公司评估资本的能力，严重影响了它们的短期和长期流动性。例如，由于 COVID-19，Bausch Health 的收入在 2020 年下降了 35% 以上。但是，在后大流行时代，经济衰退已经结束，各公司正在大举推出产品和增加开发，以促进市场增长。

全球圆锥角膜治疗市场范围

圆锥角膜治疗市场根据圆锥角膜类型、治疗、给药途径、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

圆锥角膜类型

• 角膜积水
• 圆锥角膜
• 后圆锥角膜
• 角膜球状体
• 透明边缘变性

治疗

• 镜头
• 疗法
• 外科手术
• 其他的

给药途径

• 口服
• 主题
• 肠外
• 其他的

最终用户

• 医院
• 家庭护理
• 专科诊所
• 其他的

分销渠道

• 医院药房
• 网上药店
• 零售药店

圆锥角膜治疗市场区域分析/见解

对圆锥角膜治疗市场进行了分析，并根据上述圆锥角膜类型、治疗、给药途径、最终用户和分销渠道提供了市场规模洞察和趋势。

圆锥角膜治疗市场报告涉及的主要国家 有：北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区（APAC）的其他地区、中东和非洲（MEA）的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于主要市场参与者专注于新技术或现有药物的配方，北美在预测期内一直见证着圆锥角膜治疗市场的积极增长。意识的提高和技术的进步也进一步推动了市场的增长。

亚太地区占据市场主导地位，因为该地区眼部疾病发病率高、仿制药数量多，而且该地区的并购活动和产品审批活动频繁。例如，Hoya Corporation 于 2018 年 1 月在新加坡成立了一家白内障人工晶状体研发中心。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和全球圆锥角膜治疗市场份额分析

圆锥角膜治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对圆锥角膜治疗市场的关注有关

圆锥角膜治疗市场的主要参与者包括：

• Sandoz International GmbH（德国）
• 豪雅（日本）
• Menicon 有限公司 (日本)
• 库博集团 (美国)
• Bausch Health Companies Inc.（加拿大）
• SynergEyes（美国）
• Carl Zeiss Meditec AG（德国）
• Contamac（英国）
• SEED 株式会社 (日本)
• 诺华公司（瑞士）
• 强生服务公司（美国）

SKU-52890